Enterprise Licensing for Pharma, Biotech & Startups
Data access, intelligence tools, and enterprise-grade oncology insights—built for R&D, clinical, and commercial teams
Our platform offers enterprise licensing solutions tailored for pharmaceutical companies, biotechnology firms, clinical-stage startups, and oncology innovation teams. With access to global clinical trial intelligence, biomarker analytics, market forecasting, specialist mapping, and customizable API data feeds, organizations can accelerate research, improve trial strategy, and make confident decisions at every stage of drug development.
Choose Your License Type
Designed for: Global pharma companies • Oncology portfolios • Clinical development teams
Includes:
- Full access to global clinical trials dashboard
- Biomarker-aligned insights (EGFR, KRAS, BRCA, NTRK, etc.)
- Pipeline analysis by mechanism of action
- Regulatory tracker (FDA, EMA, NMPA, PMDA, MHRA)
- Sponsor & competitor intelligence
- Global oncology market forecasting
- Trial site mapping + investigator database
- Oncology cost benchmarking (regional)
Enterprise Add-ons:
- API data pipeline
- Pre-qualified trial referral sourcing
- Custom therapeutic area reports
Designed for: Series A–Series D biotech • Cell therapy companies • Imaging & radiopharma developers
Includes:
- Access to early-phase (I/II) trial intelligence
- Partial access to pipeline monitor
- Mechanism-level research summaries
- Biomarker prevalence by geography
- Investigator & trial site database
- Country-level regulatory insights
- Company-level competitive mapping
- Inclusion in Innovation Watchlist (optional)
Enterprise Add-ons:
- Precision biomarker reports
- Pipeline competitive landscape maps
- Custom country market briefings
Designed for: Digital oncology, imaging AI, RWE companies, clinical decision-support platforms
Includes:
- API access to non-PHI clinical trial feeds
- Market landscape reports (AI diagnostics, MCED, MRD)
- Biomarker dictionary + therapy alignment
- Oncology startup ecosystem maps
- Competitive intelligence on digital oncology
- Annual trend forecasting for investors
Enterprise Add-ons:
- Inclusion in your Innovation Watchlist
- Co-marketing opportunity ("Powered by Cancer Solutions Data")
Designed for: Universities • Cancer centers • Research labs • Translational science teams
Includes:
- Full global research map
- Regional trial density analytics
- Academic partnerships directory
- Access to funding calls & programs
- Biomarker & mutation reference library
- Oncology publication digest (Nature, ASCO, ESMO)
Enterprise Add-ons:
- Lab collaboration matching
- Country research profiles in PDF
- Early-career researcher dashboard
Designed for: Health-tech developers • Oncology apps • Clinical workflow companies • Research platforms
Includes:
- Clinical trial feed (active, recruiting, by biomarker)
- Specialist directory endpoint
- Global oncology research summaries
- Biomarker dictionary endpoint
- Country cancer research metadata
- Emerging therapy pipeline data (non-PHI)
API Features:
- Volume-based pricing
- Rate-limited endpoints
- Secure token authentication
- Monthly or annual plans
The highest tier for pharma, government agencies, and multinational health systems.
Includes Everything Above Plus:
- Unlimited enterprise user seats
- Custom dashboards & private workspaces
- Weekly intelligence reports
- Dedicated account manager
- Annual strategic oncology summit invite
- Co-branded publications & research papers
- Priority access to new features
- Enterprise data export tools
- Multi-region regulatory forecasting
Premium Add-Ons:
- Disease-area deep dives (breast, lung, colorectal, hematologic)
- Global oncology alignment report for policy makers
- "Trial Feasibility Analysis" module
- API overage boosters
Enterprise FAQ
What determines my license cost?
Do you offer API trials?
Do you support white-label solutions?
Do you require long-term contracts?
Can we customize our data feeds?
What security certifications do you have?
Ready to Power Your Oncology Intelligence?
Join leading pharma companies, biotech innovators, and research institutions using our platform
